Example: Heart Attack

Clinical Trials on Human T-cell Leukemia Virus Type 2

Total 6 results





    • NCT03226119
      Completed
      MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study
      Conditions: HTLV-I Infections; HTLV-II Infections; Human T-lymphotropic Virus 1; Human T-lymphotropic Virus 2; HTLV I Associated T Cell Leukemia Lymphoma; HTLV I Associated Myelopathies
    • NCT03146013
      Completed
      Dual Algorithm Post Market Clinical Study
      Conditions: HTLV-I Infections; HTLV-II Infections; Human T-lymphotropic Virus 1; Human T-lymphotropic Virus 2; HTLV I Associated T Cell Leukemia Lymphoma; HTLV I Associated Myelopathies
    • NCT01467024
      Unknown status
      Evaluation of the MP Diagnostics HTLV Blot 2.4
      Conditions: HTLV-I Infections; HTLV-II Infections; Human T-lymphotropic Virus 1; Human T-lymphotropic Virus 2; HTLV I Associated T Cell Leukemia Lymphoma; HTLV I Associated Myelopathies
    • NCT00097006
      Completed
      Retrovirus Epidemiology Donor Study-II (REDS-II)
      Conditions: Acquired Immunodeficiency Syndrome; Blood Donors; Blood Transfusion; HIV Infections; HIV-1; HIV-2; HTLV-I; HTLV-II; Retroviridae Infections; Hepatitis, Viral, Human; Hepatitis B; Hepacivirus; West Nile Virus
    • NCT00005278
      Completed
      Retrovirus Epidemiology Donor Study I (REDS I)
      Conditions: Acquired Immunodeficiency Syndrome; Blood Donors; Blood Transfusion; HIV Infections; HIV-1; HIV-2; HTLV-I; HTLV-II; Retroviridae Infections
    • NCT01149837
      Completed
      Evaluation of InnoLIA HTLV I/II Score
      Conditions: Human T-Lymphotrophic Virus Type I and/or Type II
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations